Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives

Tadalafil is a selective phosphodiesterase type-5 (PDE5) inhibitor that is approved for the treatment of men with erectile dysfunction (ED) and/or benign prostate hyperplasia (BPH) -associated symptoms. Besides its classical actions on PDE5 within the genitourinary tract, where the specific enzyme e...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Emanuela Alessandra, Antinozzi, Cristina, Di Luigi, Luigi, Aversa, Antonio, Sgrò, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024809/
https://www.ncbi.nlm.nih.gov/pubmed/35457011
http://dx.doi.org/10.3390/ijms23084191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024809/
https://www.ncbi.nlm.nih.gov/pubmed/35457011
http://dx.doi.org/10.3390/ijms23084191

Ejemplares similares